Higher systemic elaboration of Th1 cytokines, more enhanced ratio of CD4+/CD8+ inside the tumor, and notably lower percent of Tregs inside CD4+intratumoral population (Jahan et al., 2019[36]) were achieved by this triple combination immunotherapy. This evidence concerns the gene CD8A and neoplasm.